HCIL Hongchang International Co., Ltd

OTC Electromedical & Electrotherapeutic Apparatus NV CIK: 0001086303
AI RATING
SELL
68% Confidence

Investment Thesis

Company demonstrates positive net income ($1.0M) but exhibits critical cash flow deterioration with negative operating cash flow (-$641.3K) and free cash flow (-$1.5M), indicating severe earnings quality concerns. Acute liquidity crisis with current ratio 0.85x and dangerously low cash reserves ($551.8K) against $22.2M liabilities creates existential solvency risk.

Strengths

  • + Positive net income and acceptable 10% operating margin demonstrate underlying business profitability
  • + Conservative leverage with 0.16x debt-to-equity ratio provides some balance sheet cushion
  • + Minimal debt service burden with 1118x interest coverage ratio

Risks

  • ! Severe cash flow deterioration: negative operating cash flow and negative $1.5M free cash flow indicate earnings are not converting to cash
  • ! Critical liquidity crisis: current ratio 0.85x and quick ratio 0.84x both below 1.0x with only $551.8K cash against $22.2M liabilities
  • ! Extremely poor capital efficiency with ROE of only 2.4% and ROA of 1.5%, suggesting capital is underdeployed
  • ! Small $11.3M revenue base limits financial flexibility and ability to absorb shocks

Key Metrics to Watch

Financial Metrics

Revenue
11.3M
Net Income
1.0M
EPS (Diluted)
$0.00
Free Cash Flow
-1.5M
Total Assets
65.9M
Cash
551.8K

Profitability Ratios

Gross Margin 17.1%
Operating Margin 10.0%
Net Margin 8.8%
ROE 2.4%
ROA 1.5%
FCF Margin -13.2%

Balance Sheet & Liquidity

Current Ratio
0.85x
Quick Ratio
0.84x
Debt/Equity
0.16x
Debt/Assets
33.7%
Interest Coverage
1,118.04x
Long-term Debt
6.9M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-11T01:45:24.707624 | Data as of: 2025-12-31 | Powered by Claude AI